ABSTRACT NUMBER: ESOC2026A1640 THE IMPACT OF THE COVID-19 PANDEMIC ON THE MANAGEMENT OF STROKE AT AHEPA UNIVERSITY GENERAL HOSPITAL IN GREECE: HOSPITALIZATION METRICS AND HEALTCARE-ASSOCIATED INFECTIONS

Abstract Background and aims Stroke represents the second leading cause of death worldwide. The COVID-19 pandemic disrupted healthcare systems, affecting stroke hospitalization, treatments and healthcare-associated infections. The aim of the study was to assess these effects on stroke patients at AHEPA University General Hospital in Greece. Methods A retrospective study, comparing two periods: the pre-COVID-19 period (01/01/2019-10/03/2020) and the COVID-19 period (11/03/2020-31/12/2021). A total of 322 patients (155 and 167 respectively) with acute stroke were included. Results Hospital admissions declined 38% in 2020 (85 vs. 137), with 55.5% reduction in Q4, partially recovering to 100 in 2021. Mean patient age decreased significantly (66.2 vs. 63.4 years, p=0.038). Stroke subtype distribution shifted (p=0.049): increased ischemic strokes (75.4% vs. 72.3%) and TIAs (10.2% vs. 4.5%), decreased intracerebral hemorrhages (13.2% vs. 22.6%). Median length of stay, stroke severity, and ICU admissions remained unchanged. Acute-phase therapies were maintained, though with decreased use of thrombolysis (8.7% vs. 16.1%) and an increase in mechanical thrombectomy (2.4% vs. 1.8%) and combined therapy (4.0% vs. 0.9%). Lipid-lowering therapies increased significantly (73.1% vs. 60.0%, p=0.013). Overall healthcare-associated infection rates were unchanged (32.9% vs. 34.2%; p=0.811), but specific patterns shifted: urinary tract infections increased (15.0% vs. 2.6%, p<0.001), fevers of unknown origin decreased (2.4% vs. 11.6%, p=0.001) and respiratory complications decreased (4.2% vs. 10.3%, p=0.033). Conclusions The COVID-19 pandemic significantly affected stroke management, causing reduced admissions while preserving care quality. Stricter protocols improved specific metrics and reduced hospital-acquired infections, demonstrating healthcare system resilience and the importance of adapting management strategies during health crises. Conflict of interest Dimitrios Digkas: nothing to disclose

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1625
Primary Topic
COVID-19 and healthcare impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1640 THE IMPACT OF THE COVID-19 PANDEMIC ON THE MANAGEMENT OF STROKE AT AHEPA UNIVERSITY GENERAL HOSPITAL IN GREECE: HOSPITALIZATION METRICS AND HEALTCARE-ASSOCIATED INFECTIONS

Theodoros Karapanayiotides, Athanasios Terzakis, Ioanna Koutroulou, Dimitrios Digkas et al.
European Stroke Journal
COVID-19 and healthcare impacts
article

ABSTRACT NUMBER: ESOC2026A1640 THE IMPACT OF THE COVID-19 PANDEMIC ON THE MANAGEMENT OF STROKE AT AHEPA UNIVERSITY GENERAL HOSPITAL IN GREECE: HOSPITALIZATION METRICS AND HEALTCARE-ASSOCIATED INFECTIONS

Theodoros Karapanayiotides, Athanasios Terzakis, Ioanna Koutroulou, Dimitrios Digkas, Tsampikos Papastogiannis, Nikolaos Grigoriadis
article en

Abstract

Abstract Background and aims Stroke represents the second leading cause of death worldwide. The COVID-19 pandemic disrupted healthcare systems, affecting stroke hospitalization, treatments and healthcare-associated infections. The aim of the study was to assess these effects on stroke patients at AHEPA University General Hospital in Greece. Methods A retrospective study, comparing two periods: the pre-COVID-19 period (01/01/2019-10/03/2020) and the COVID-19 period (11/03/2020-31/12/2021). A total of 322 patients (155 and 167 respectively) with acute stroke were included. Results Hospital admissions declined 38% in 2020 (85 vs. 137), with 55.5% reduction in Q4, partially recovering to 100 in 2021. Mean patient age decreased significantly (66.2 vs. 63.4 years, p=0.038). Stroke subtype distribution shifted (p=0.049): increased ischemic strokes (75.4% vs. 72.3%) and TIAs (10.2% vs. 4.5%), decreased intracerebral hemorrhages (13.2% vs. 22.6%). Median length of stay, stroke severity, and ICU admissions remained unchanged. Acute-phase therapies were maintained, though with decreased use of thrombolysis (8.7% vs. 16.1%) and an increase in mechanical thrombectomy (2.4% vs. 1.8%) and combined therapy (4.0% vs. 0.9%). Lipid-lowering therapies increased significantly (73.1% vs. 60.0%, p=0.013). Overall healthcare-associated infection rates were unchanged (32.9% vs. 34.2%; p=0.811), but specific patterns shifted: urinary tract infections increased (15.0% vs. 2.6%, p<0.001), fevers of unknown origin decreased (2.4% vs. 11.6%, p=0.001) and respiratory complications decreased (4.2% vs. 10.3%, p=0.033). Conclusions The COVID-19 pandemic significantly affected stroke management, causing reduced admissions while preserving care quality. Stricter protocols improved specific metrics and reduced hospital-acquired infections, demonstrating healthcare system resilience and the importance of adapting management strategies during health crises. Conflict of interest Dimitrios Digkas: nothing to disclose

European Stroke JournalVol. 11(Supplement_1)
AHEPA University Hospital (GR)
Good health and well-being
Openalex Percentile: Top 9%
COVID-19 and healthcare impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.